
Champions Oncology Inc
NASDAQ:CSBR

Intrinsic Value
The intrinsic value of one
CSBR
stock under the Base Case scenario is
6.36
USD.
Compared to the current market price of 5.98 USD,
Champions Oncology Inc
is
Undervalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Champions Oncology Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Champions Oncology Inc
Balance Sheet Decomposition
Champions Oncology Inc
Current Assets | 19.7m |
Cash & Short-Term Investments | 3.2m |
Receivables | 15.8m |
Other Current Assets | 713k |
Non-Current Assets | 10.9m |
PP&E | 10.4m |
Intangibles | 335k |
Other Non-Current Assets | 185k |
Free Cash Flow Analysis
Champions Oncology Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Champions Oncology Inc
Revenue
|
58.6m
USD
|
Cost of Revenue
|
-28.4m
USD
|
Gross Profit
|
30.2m
USD
|
Operating Expenses
|
-23.9m
USD
|
Operating Income
|
6.3m
USD
|
Other Expenses
|
138k
USD
|
Net Income
|
6.4m
USD
|
CSBR Profitability Score
Profitability Due Diligence
Champions Oncology Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Score
Champions Oncology Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
CSBR Solvency Score
Solvency Due Diligence
Champions Oncology Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Score
Champions Oncology Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CSBR Price Targets Summary
Champions Oncology Inc
According to Wall Street analysts, the average 1-year price target for
CSBR
is 12.24 USD
with a low forecast of 12.12 USD and a high forecast of 12.6 USD.
Dividends
Current shareholder yield for CSBR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CSBR
stock under the Base Case scenario is
6.36
USD.
Compared to the current market price of 5.98 USD,
Champions Oncology Inc
is
Undervalued by 6%.